Mediterranean diet, physical activity and subcutaneous advanced glycation end-products' accumulation: a cross-sectional analysis in the ILERVAS project.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 19 12 2018
accepted: 26 04 2019
pubmed: 9 5 2019
medline: 29 1 2021
entrez: 9 5 2019
Statut: ppublish

Résumé

Adherence to Mediterranean diet (MedDiet) and physical activity have been associated to lower cardiovascular risk and mortality. Our purpose was to test the modification of advanced glycation end-products (AGEs) as one of the underlying mechanisms explaining this relationship. Cross-sectional study assessing the adherence to MedDiet (14-item Mediterranean Diet Adherence Screener) and physical activity (International Physical Activity Questionnaire short form) in 2646 middle-aged subjects without known cardiovascular disease and type 2 diabetes from the ILERVAS study. Skin autofluorescence (SAF), a non-invasive assessment of subcutaneous AGEs, was measured. Multivariable logistic regression models were done to study interactions and independent associations with a likelihood ratio test. Participants with a high adherence to MedDiet had lower SAF than those with low adherence (1.8 [IR 1.6; 2.1] vs. 2.0 [IR 1.7; 2.3] arbitrary units, p < 0.001), without differences according to categories of physical activity. There was an independent association between high adherence to MedDiet and the SAF values [OR 0.59 (0.37-0.94), p = 0.026]. When adherence to MedDiet was substituted by its individual food components, high intake of vegetables, fruits and nuts, and low intake of sugar-sweetened soft beverages were independently associated with a decreased SAF (p ≤ 0.045). No interaction between MedDiet and physical activity on SAF values was observed except for nuts consumption (p = 0.047). Adherence to the MedDiet, but not physical activity, was negatively associated to SAF measurements. This association can be explained by some typical food components of the MedDiet. The present study offers a better understanding of the plausible biological conditions underlying the prevention of cardiovascular disease with MedDiet. ClinTrials.gov identifier: NCT03228459.

Identifiants

pubmed: 31065845
doi: 10.1007/s00394-019-01983-w
pii: 10.1007/s00394-019-01983-w
doi:

Substances chimiques

Glycation End Products, Advanced 0

Banques de données

ClinicalTrials.gov
['NCT03228459']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1233-1242

Subventions

Organisme : Generalitat de Catalunya
ID : 2017SGR696
Organisme : Generalitat de Catalunya
ID : SLT0021600250
Organisme : Instituto de Salud Carlos III
ID : Action Plan II14//00008

Références

Exp Gerontol. 2017 May;91:9-14
pubmed: 28189699
Nutrients. 2018 Jul 27;10(8):
pubmed: 30060512
Diseases. 2018 Aug 08;6(3):
pubmed: 30096779
Osteoporos Int. 2012 Jun;23(6):1673-81
pubmed: 21901479
J Clin Med Res. 2011 Oct;3(5):252-7
pubmed: 22383913
Arch Intern Med. 2007 Jun 11;167(11):1195-1203
pubmed: 17563030
Adv Nutr. 2014 Nov 14;5(6):797-808
pubmed: 25398745
J Am Geriatr Soc. 2016 Apr;64(4):901-4
pubmed: 27100598
Public Health Nutr. 2004 Oct;7(7):943-7
pubmed: 15482622
Age (Dordr). 2014;36(4):9665
pubmed: 24997017
Prog Cardiovasc Dis. 2018 May - Jun;61(1):62-67
pubmed: 29678447
J Diabetes Investig. 2017 May;8(3):377-382
pubmed: 27727515
BMJ. 2015 Jul 21;351:h3576
pubmed: 26199070
Ann Epidemiol. 2009 May;19(5):316-22
pubmed: 19230711
Am J Clin Nutr. 2009 Jan;89(1):248-56
pubmed: 19056596
BMC Med. 2014 Jul 24;12:112
pubmed: 25055810
Diabetes. 1998 Jun;47(6):945-52
pubmed: 9604873
Eur J Nutr. 2018 Sep;57(6):2209-2216
pubmed: 28656390
Ann Intern Med. 2006 Jul 4;145(1):1-11
pubmed: 16818923
Molecules. 2018 Jul 11;23(7):
pubmed: 29997312
Eur J Heart Fail. 2011 Jan;13(1):76-82
pubmed: 20861128
Circulation. 2010 Feb 16;121(6):750-8
pubmed: 20124123
BMJ. 2009 Jun 23;338:b2337
pubmed: 19549997
Clin Exp Hypertens. 2015;37(7):587-93
pubmed: 26114357
J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1545-1551
pubmed: 29718128
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
Circulation. 1995 Aug 1;92(3):518-25
pubmed: 7543382
Diabetes Care. 2013 Oct;36(10):3062-9
pubmed: 23757430
Circulation. 2010 Sep 21;122(12):1221-38
pubmed: 20855669
Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):809-14
pubmed: 15692095
Cell Metab. 2018 Sep 4;28(3):337-352
pubmed: 30184484
N Engl J Med. 2018 Jun 21;378(25):2441-2442
pubmed: 29897867
Med Clin (Barc). 2012 May 19;138(14):617-21
pubmed: 22444996
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Circulation. 2014 Jun 24;129(25 Suppl 2):S76-99
pubmed: 24222015
Geriatr Gerontol Int. 2017 May;17(5):785-790
pubmed: 27119258
J Vasc Surg. 2004 Jul;40(1):187-93
pubmed: 15218485
Nutrients. 2016 Mar 15;8(3):168
pubmed: 26999195
Diabetologia. 2004 Jul;47(7):1324-1330
pubmed: 15243705
Br J Nutr. 2014 May 28;111(10):1871-80
pubmed: 24480368
Nefrologia. 2016 Jul-Aug;36(4):389-96
pubmed: 27044887
J Nutr. 2011 Jun;141(6):1140-5
pubmed: 21508208
Eur J Appl Physiol. 2011 Jul;111(7):1545-52
pubmed: 21188413
Eur Heart J. 2014 May;35(17):1137-46
pubmed: 24126878
Circulation. 2017 Oct 10;136(15):1434-1448
pubmed: 28993373
J Am Diet Assoc. 2010 Jun;110(6):911-16.e12
pubmed: 20497781
Int J Clin Pract. 2017 Feb;71(2):
pubmed: 28074617
Nutrients. 2015 Nov 05;7(11):9116-26
pubmed: 26556367
Amino Acids. 2003 Dec;25(3-4):275-81
pubmed: 14661090
Circulation. 2003 Jul 1;107(25):3152-8
pubmed: 12810615
Nutr Hosp. 2015 Jun 01;31(6):2511-7
pubmed: 26040359
Clin Ther. 2018 Jun;40(6):872-880
pubmed: 29567299
Med Sci Sports Exerc. 2018 Jul;50(7):1502-1507
pubmed: 29462102
Nephrology (Carlton). 2014 Dec;19(12):791-7
pubmed: 25251417
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Curr Pharm Des. 2016;22(24):3700-14
pubmed: 27000827
Atheroscler Suppl. 2017 Apr;26:2-15
pubmed: 28434481
Ann Intern Med. 2001 Jun 19;134(12):1115-9
pubmed: 11412051
Eur J Prev Cardiol. 2018 Jul;25(11):1186-1197
pubmed: 29944010
Diabetes Technol Ther. 2010 May;12(5):399-403
pubmed: 20388050
Curr Drug Metab. 2016;17(6):598-607
pubmed: 26953241

Auteurs

Enric Sánchez (E)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism (ODIM) Research Group, IRBLleida, University of Lleida, Avda. Rovira Roure 80, 25198, Lleida, Catalonia, Spain.

Àngels Betriu (À)

Unit for the Detection and Treatment of Atherothrombotic Diseases (UDETMA V&R), University Hospital Arnau de Vilanova, Vascular and Renal Translational Research Group, IRBLleida, University of Lleida, Lleida, Catalonia, Spain.

Jordi Salas-Salvadó (J)

Department of Human Nutrition Unit, Biochemistry and Biotechnology, Faculty of Medicine and Health Sciences, University Hospital of Sant Joan de Reus, IISPV, Rovira i Virgili University, Reus, Spain.
Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Reinald Pamplona (R)

Experimental Medicine Department, IRBLleida, University of Lleida, Lleida, Catalonia, Spain.

Ferrán Barbé (F)

Respiratory Department, University Hospital Arnau de Vilanova-Santa María, Translational Research in Respiratory Medicine, IRBLleida, University of Lleida, Lleida, Catalonia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Francesc Purroy (F)

Stroke Unit, University Hospital Arnau de Vilanova, Clinical Neurosciences Group, IRBLleida, University of Lleida, Lleida, Catalonia, Spain.

Cristina Farràs (C)

Primary Health Care Unit, Lleida, Catalonia, Spain.

Elvira Fernández (E)

Unit for the Detection and Treatment of Atherothrombotic Diseases (UDETMA V&R), University Hospital Arnau de Vilanova, Vascular and Renal Translational Research Group, IRBLleida, University of Lleida, Lleida, Catalonia, Spain.

Carolina López-Cano (C)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism (ODIM) Research Group, IRBLleida, University of Lleida, Avda. Rovira Roure 80, 25198, Lleida, Catalonia, Spain.

Chadia Mizab (C)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism (ODIM) Research Group, IRBLleida, University of Lleida, Avda. Rovira Roure 80, 25198, Lleida, Catalonia, Spain.

Albert Lecube (A)

Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism (ODIM) Research Group, IRBLleida, University of Lleida, Avda. Rovira Roure 80, 25198, Lleida, Catalonia, Spain. alecube@gmail.com.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. alecube@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH